Cargando…
The Role of Runx2 in Microtubule Acetylation in Bone Metastatic Breast Cancer Cells
SIMPLE SUMMARY: Breast cancer is the most commonly diagnosed cancer type, making up a quarter of all cases among women. While modern-day research has shown tremendous progress in the development of treatment options, complications related to bone metastasis remain an obstacle that demands further at...
Autores principales: | Othman, Ahmad, Winogradzki, Marcus, Patel, Shreya, Holmes, Waddell, Blank, Alan, Pratap, Jitesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323014/ https://www.ncbi.nlm.nih.gov/pubmed/35884497 http://dx.doi.org/10.3390/cancers14143436 |
Ejemplares similares
-
Bone Metastatic Breast Cancer: Advances in Cell Signaling and Autophagy Related Mechanisms
por: Othman, Ahmad, et al.
Publicado: (2021) -
Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells
por: Tandon, Manish, et al.
Publicado: (2014) -
Runx2 Association with Progression of Prostate Cancer in Patients: Mechanisms Mediating Bone Osteolysis and Osteoblastic Metastatic Lesions
por: Akech, Jacqueline, et al.
Publicado: (2009) -
Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells
por: Tandon, Manish, et al.
Publicado: (2012) -
Cancer-related ectopic expression of the bone-related transcription factor RUNX2 in non-osseous metastatic tumor cells is linked to cell proliferation and motility
por: Leong, David T, et al.
Publicado: (2010)